Sanofi reported second quarter revenue of €9.1 billion, a gain of 3.9% or €346 million from the year earlier figure. Remarkably, the French pharmaceutical company was able to keep its operating costs at very close to those a year earlier. ---Subscribe to MedNous to access this article--- Company News
